More than a mess: Research finds disorganized homes increase stress - Coast Reporter

Skip to Content Home Filter by region Nova Scotia Halifax Local Sports Local Business Local Opinion Annapolis Valley Truro Tri-County New Glasgow South Shore Antigonish Cape Breton Prince Edward Island Summerside Newfoundland & Labrador News Canada Health World Opinion Editorial Cartoons Business Local Business Sports Local Sports Baseball Basketball Football Hockey Entertainment & Life Food Homes Savings Special Sections Lives Told Tails Told Shopping Essentials Deals Entertainment & Hobbies Gift Guide Home Living Kitchen & Dining Outdoor Living Personal Care Style & Beauty Tech Travel Guide PNI Atlantic Store ePaper Puzzmo Newsletters Travel Business Ads Obituaries Classifieds Jobs Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Profile Settings My Subscriptions Newsletters Customer Service FAQ News Opinion Business Sports Entertainment & Life Special Sections Shopping Essentials ePaper Puzzmo Newsletters Travel Business Ads Obituaries Classifieds Jobs The Magnetic World music festival crowd view at the Garrison Grounds in Halifax.

The new treatment kills off a sub-group of fat cells. (Jian Fan/iStockphoto/Getty Images) Early clinical trials into a new fat reduction treatment have reported promising results, and the treatment takes a more unusual approach: Rather than shrinking fat cells, as most weight loss strategies do, it safely and naturally kills them off. The drug here is CBL-514, which is administered via injection. As well as proving effective at reducing subcutaneous fat (just below the skin), there's evidence it can also reduce visceral fat (stored deeper around the organs). According to the team behind the trials, CBL-514 and its unconventional strategy have the potential to reduce fat in key areas of the body – with further benefits that come with weight loss likely to follow. "We expect that patients will be pleased by the cosmetic effects, such as the flatter stomach that can come with subcutaneous fat loss," says endocrinologist Timothy Garvey, from the University of Alabama at Birmingham, who headed up the trial.